Last reviewed · How we verify

NCT05459727

Effects of Non-surgical Periodontal Therapy on Cardiovascular Risk

Not yet recruiting NA Last updated 15 July 2022
What this trial tests

NA trial testing Non-surgical periodontal therapy in Cardiovascular Diseases in 376 participants. Not yet recruiting.

Timeline
1 August 2022
Primary endpoint
31 August 2025
31 December 2026

Quick facts

Lead sponsorNanfang Hospital, Southern Medical University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment376
Start date1 August 2022
Primary completion31 August 2025
Estimated completion31 December 2026
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Nanfang Hospital, Southern Medical University

Who can join

18 and older, any sex, with Cardiovascular Diseases or Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to evaluate whether non-surgical periodontal therapy can help to control the cardiovascular risk among patients with moderate/severe periodontitis and at risk of cardiovascular disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Non-surgical periodontal therapy

Trials testing the same drug.

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Nanfang Hospital, Southern Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05459727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing